TrialReader


Right Ventricular Function at Rest in Highlanders/Lowlanders

NCT03165656 — Completed, 173 participants, University of Zurich

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Right Ventricular Function at Rest in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders

RegistryNCT03165656
StatusCompleted
Study typeObservational
Enrollment173 (Actual)
SponsorUniversity of Zurich (Other); collaborators: National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
ConditionsHigh Altitude Pulmonary Hypertension
Datesstart 2017-05-24, primary completion 2017-08-16, completion 2017-08-16, first posted 2017-05-24, last updated 2019-08-16
Locations1 site in Kyrgyzstan

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for High Altitude Pulmonary Hypertension

-Summary

The purpose of the current study is to evaluate the progression of right ventricular function and dimension in Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a cross sectional case-control study.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
High altitude pulmonary hypertensionHighlanders with high altitude pulmonary hypertension living above 2500 m.
High altitude controlHealthy highlanders living above 2500 m.
Low altitude controlHealthy lowlanders living below 1000 m.

+Outcome measures

Primary outcomes

  • Pulmonary artery pressure [Day 2]: Difference between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders in tricuspid pressure gradient, measured by transthoracic echocardiography

Secondary outcomes

  • cardiac output [Day 2]: Difference between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders in cardiac output, measured by transthoracic echocardiography
  • right heart dimensions [Day 2]: Difference of right heart dimensions between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography
  • Right heart function [Day 2]: Differences of right heart function between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography (TAPSE)
  • stroke volume [Day 2]: Difference between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders in stroke volume, measured by transthoracic echocardiography
  • volumes [Day 2]: Difference of volumes between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography

+Eligibility

Sex: All, ages: 16 Years to any

Inclusion Criteria:

* high altitude pulmonary hypertension confirmed by clinical presentation and mean pulmonary artery pressure >30 mmHg measured by echocardiography at altitude of residence.
* healthy subjects (high altitude controls)
* Both genders
* Age >16 y
* Kyrgyz ethnicity
* born, raised and currently living at >2500 m
* healthy subjects currently living at <1000 m (low altitude controls)

Exclusion Criteria:

* Pulmonary hypertension from other causes, in particular from left ventricular failure as judged clinically and by echocardiography
* Excessive erythrocytosis
* Other coexistent disorders that may interfere with the cardio-respiratory system and sleep
* Regular use of medication that affects control of breathing
* Heavy smoking

+Locations (1)

FacilityCityCountryStatus
National Center for Cardiology and Internal MedicineBishkekKyrgyzstan

+Publications

  • Results publication: Gosens R, Hiemstra PS, Adcock IM, Bracke KR, Dickson RP, Hansbro PM, Krauss-Etschmann S, Smits HH, Stassen FRM, Bartel S. Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. Eur Respir J. 2020 Aug 20;56(2):1902320. doi: 10.1183/13993003.02320-2019. Print 2020 Aug. PMID 32430415

+Investigators

My Notes